Abstract:Background:Deregulated inflammation has been implicated in the development of renal interstitial fibrosis and progressive renal failure. Previous work has established that fluorofenidone, a pyridone agent, attenuates renal fibrosis. However, the mechanism by which fluorofenidone prevents renal fibrosis remains unclear. The aim of this study was to investigate the in vivo effects of fluorofenidone on unilateral ureteral obstruction-induced fibrosis and the involved molecular mechanism in mouse peritoneal macrophages.Methods:Renal fibrosis was induced in rat by unilateral ureteral obstruction for 3, 7 or 14 days. Ipsilateral kidneys were harvested for morphologic analysis. Leukocyte infiltration was assessed by immunohistochemistry staining. The expression of chemokines (MCP-1, RANTAS, IP-10, MIP-1 alpha and MIP-1 beta) and pro-inflammatory cytokines (TNF-alpha and IL-1 beta) was measured by enzyme-linked immunosorbent assay and real-time polymerase chain reaction. Mouse peritoneal macrophages and HK-2 cells were incubated with necrotic MES-13 cells or TNF-alpha in the presence or absence of fluorofenidone. The production of MCP-1 was measured by enzyme-linked immunosorbent assay, and phosphorylation of ERK1/2, p38 and JNK was quantified by Western blot.Results:Fluorofenidone treatment hampered renal pathologic change and interstitial collagen deposition. Leukocyte infiltration and the expression of chemokines (MCP-1, RANTES, IP-10, MIP-1 alpha and MIP-1 beta) and pro-inflammatory cytokines (IL-1 alpha) in kidney were significantly reduced by fluorofenidone treatment. Mechanistically, fluorofenidone significantly inhibited TNF-alpha or necrotic cell-induced activation of MAP kinase pathways in vitro.Conclusions:Fluorofenidone serves as a novel anti-inflammatory agent that attenuates ureteral obstruction-induced renal interstitial inflammation and fibrosis, possibly through the inhibition of the microtubule-associated protein kinase pathways.

Fluorofenidone Protects Mice from Lethal Endotoxemia Through the Inhibition of TNF-α and IL-1β Release

Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway

Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-B Pathway

Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway

Fluorofenidone Inhibits Macrophage IL-1β Production by Suppressing Inflammasome Activity

The Antihepatic Fibrotic Effects of Fluorofenidone Via Mapk Signalling Pathways

Pentoxifylline Protects Against Endotoxin-Induced Acute Renal Failure in Mice.

Fluorofenidone Protects Liver Against Inflammation and Fibrosis by Blocking the Activation of NF‐κB Pathway

Fluorofenidone Attenuates Inflammation by Inhibiting the NF-кB Pathway.

Paeoniflorin improves survival in LPS-challenged mice through the suppression of TNF-α and IL-1β release and augmentation of IL-10 production

Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway

The Protective Mechanism of Fluorofenidone in Renal Interstitial Inflammation and Fibrosis

Effects of Florfenicol on Early Cytokine Responses and Survival in Murine Endotoxemia

Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

Fluorofenidone Attenuates Hepatic Fibrosis By Suppressing The Proliferation And Activation Of Hepatic Stellate Cells

Effects of Florfenicol on Early Cytokine Response and Survival in a Murine Septic Shock Model

Inhibition of Fibroblast Growth Factor Receptor by AZD4547 Protects Against Inflammation in Septic Mice

A Novel Fibrinogenase from Agkistrodon Acutus Venom Protects Against LPS-induced Endotoxemia Via Regulating NF-κB Pathway.

Dimethyl Fumarate Protects against Lipopolysaccharide- (LPS-) Induced Sepsis through Inhibition of NF-κB Pathway in Mice

Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice

A Novel Small Molecule, HK-156, Inhibits Lipopolysaccharide-Induced Activation of NF-κB Signaling and Improves Survival in Mouse Models of Sepsis